Citations

Citations to this article as recorded by  

• Molecular and cellular secrets revealed: How umbilical cord-derived mesenchymal stem cells can target hepatocellular carcinoma
  Mohammad Sadegh Izadi, Reza Arefnezhad, Amirmasoud Asadi, Aryan Rezaee, Leila Kalantari, Farzad Nasrpour Tahouneh, Mohammad Mehdi Shadravan, Seyyed Taher Seyyed Mahmoudi, Zahra GhaniBeygi, Fatemeh Rostamnezhad, Armin Razman, Fardad Ejtehadi, Fatemeh Rezae
  Tissue and Cell.2026; 98: 103200.     CrossRef
• Diagnostic Utility of Apparent Diffusion Coefficient Values of Spleen and Liver in Assessment of Severity of Portal Hypertension and Liver Cirrhosis
  Kommuri Siddhardha, S. Jalaludheen, Senthil Kumar Aiyappan
  Nigerian Postgraduate Medical Journal.2026; 33(1): 118.     CrossRef
• Head to head: should portal inflammation be part of grading necroinflammatory activity in metabolic dysfunction‐associated steatotic liver disease?
  Daniela Allende, Alastair D Burt
  Histopathology.2026;[Epub]     CrossRef
• Diagnostic accuracy of deep learning-enhanced MRI techniques for liver fibrosis and cirrhosis detection: a systematic review and meta-analysis
  Mohammadreza Elhaie, Abolfazl Koozari, Iraj Abedi
  Egyptian Liver Journal.2026;[Epub]     CrossRef
• Physical Activity and Liver Fibrosis: A Stratified Analysis by Obesity and Diabetes Status
  Junghwan Cho, Sunghwan Suh, Ji Min Han, Hye In Kim, Hanaro Park, Hye Rang Bak, Ji Cheol Bae
  Journal of Clinical Medicine.2026; 15(2): 757.     CrossRef
• Serum Kallistatin level as a biomarker for evaluation of liver function status in cirrhotic patients
  Mahmoud Rizk, F. M. Khalil, Mohamed El-Assal, Hussien Ali, Ahmed R. Mohamed, Samer S. Zekry, Abeer Mahmoud El-Bahy, Amira Kamal ElDin Mohammed ElAlfy
  Egyptian Liver Journal.2026;[Epub]     CrossRef
• The Dual-Faceted Role of Metal-Based Nanomaterials in Hepatic Fibrosis Therapy
  Yinqing Mao, Yankai Gong, Xue Bai
  International Journal of Nanomedicine.2026; Volume 21: 1.     CrossRef
• Reply to the Letter on “Clinical implications of fibrosis marker dynamics after hepatitis C cure: insights from paired biopsies”
  Hung-Wei Wang, Cheng-Yuan Peng
  Journal of the Formosan Medical Association.2026;[Epub]     CrossRef
• Low-Grade Chronic Inflammation: a Shared Mechanism for Chronic Diseases
  Mariana Cifuentes, Hugo E. Verdejo, Pablo F. Castro, Alejandro H. Corvalan, Catterina Ferreccio, Andrew F. G. Quest, Marcelo J. Kogan, Sergio Lavandero
  Physiology.2025; 40(1): 4.     CrossRef
• Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
  Melchor Alpízar Salazar, Samantha Estefanía Olguín Reyes, Andrea Medina Estévez, Julieta Alejandra Saturno Lobos, Jesús Manuel De Aldecoa Castillo, Juan Carlos Carrera Aguas, Samary Alaniz Monreal, José Antonio Navarro Rodríguez, Dulce María Fernanda Alpí
  Medicina.2025; 61(1): 88.     CrossRef
• Unveiling the Link between Albumin-Bilirubin Grade and Liver Fibrosis in Patients with a History of Gallstone and Gallbladder Surgery: A Focus on Metabolic Dysfunction-Associated Steatohepatitis
  Mohammadjavad Sotoudeheian
  The Korean Journal of Pancreas and Biliary Tract.2025; 30(1): 10.     CrossRef
• Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
  Marina W. Takawy, Manal F. Abdelmalek
  Current Diabetes Reports.2025;[Epub]     CrossRef
• Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights
  Sathiyamoorthy Padmanaban, Ji-Won Baek, Sai Sahithya Chamarthy, Saipriya Chandrasekaran, Antony V Samrot, Vijayakumar Gosu, In-Kyu Park, Kamalakannan Radhakrishnan, Don-Kyu Kim
  Liver Research.2025; 9(2): 104.     CrossRef
• Innovative Strategies in the Diagnosis and Treatment of Liver Cirrhosis and Associated Syndromes
  Ashok Kumar Sah, Mohd Afzal, Rabab H. Elshaikh, Anass M. Abbas, Manar G. Shalabi, Pranav Kumar Prabhakar, Asaad M. A. Babker, Fariza Tursunbaevna Khalimova, Velilyaeva Aliya Sabrievna, Ranjay Kumar Choudhary
  Life.2025; 15(5): 779.     CrossRef
• Poly(I:C)-Stimulated Exosomes Mitigate Cholesterol-Induced Hepatic Fibrosis by Modulating the TGF-β/Smad3 Signal Transduction Pathway
  Shahla Asadizadeh, Parichehreh Yaghmaei, Nasim Hayati Roodbari, Azam Khedri
  Hepatitis Monthly.2025;[Epub]     CrossRef
• The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial
  Johanne K. Hansen, Mads Israelsen, Suguru Nishijima, Sara E. Stinson, Peter Andersen, Stine Johansen, Camilla D. Hansen, Maximilian Joseph Brol, Sabine Klein, Robert Schierwagen, Frank Erhard Uschner, Karolina Sulek, Ida F. Villesen, Katrine P. Lindvig, K
  Nature Communications.2025;[Epub]     CrossRef
• ADVANCING CURCUMIN APPLICATIONS IN HEPATOCELLULAR CARCINOMA: INSIGHTS INTO PHARMACOKINETICS, PHARMACODYNAMICS AND NANODELIVERY SYSTEMS
  RESHMA T. MATE, ANURADHA N. CHIVATE, NAMDEO R. JADHAV, NIRANJAN D. CHIVATE
  International Journal of Applied Pharmaceutics.2025; : 19.     CrossRef
• Genetic Determinants of Apoptosis Regulate Liver Cirrhosis Risk: The FAS/FASL Polymorphism Connection in Iraqi Population
  Wisam Hindawi Hoidy, Ahmed Ghdhban Al-Ziaydi
  Indian Journal of Clinical Biochemistry.2025;[Epub]     CrossRef
• Histological and Molecular Evaluation of Liver Biopsies: A Practical and Updated Review
  Joon Hyuk Choi
  International Journal of Molecular Sciences.2025; 26(16): 7729.     CrossRef
• Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation
  Sachin Sharma, Vijaya Prathigudupu, Carson Cable, Lia R. Serrano, Srilaxmi Nerella, Alina Chen, Ghmkin Hassan, Johnathon Lakins, Carlos Lizama Valenzuela, Tatsuya Tsukui, Roopa Ramamoorthi, Jae-Jun Kim, Holger Willenbring, Aras N. Mattis, Regan F. Volk, B
  Science Translational Medicine.2025;[Epub]     CrossRef
• Association of ANGPT2 and NOS3 Gene Variants With Esophageal Variceal Progression in HCV‐Induced Cirrhosis
  Omnia S. Nabih, Mohamed Abdel‐Samiee, Marwa A. Tahoon, Elaf Abozeid, Heba Demerdash, Fatma Omar Khalil, Randa M. Seddik, Marwa L. Helal, Gamalat A. El Gedawy, HalaA E. Khalil, Badawy W AboBakr. Yossef, Ahmed B. Zaid, Mai I. Elashmawy
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis
  Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, Yuliang Wang
  The Egyptian Journal of Internal Medicine.2024;[Epub]     CrossRef
• Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action
  Vasudevan Sekar, Venkateish VP, Vani Vijay, Annapoorna BR, Nivya Vijayan, Madan Kumar Perumal
  Journal of Food Science and Technology.2024; 61(11): 2046.     CrossRef
• The Role of Macrophage Inhibitory Factor in TAA-Induced Liver Fibrosis in Mice: Modulatory Effects of Betaine
  Tatjana Radosavljevic, Dusan Vukicevic, Jasmina Djuretić, Kristina Gopcevic, Milica Labudovic Borovic, Sanja Stankovic, Janko Samardzic, Milica Radosavljevic, Danijela Vucevic, Vladimir Jakovljevic
  Biomedicines.2024; 12(6): 1337.     CrossRef
• Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression
  Anindita Banerjee, Patrizia Farci
  International Journal of Molecular Sciences.2024; 25(16): 8641.     CrossRef
• Multiomic predictors for regression of cirrhosis: Clinical implications and future directions
  Binghua Li, Decai Yu
  iLIVER.2024; 3(4): 100116.     CrossRef
• Commonly encountered symptoms and their management in patients with cirrhosis
  Cyriac Abby Philips
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Antioxidant Potential of Xanthohumol in Disease Prevention: Evidence from Human and Animal Studies
  Jakub Piekara, Dorota Piasecka-Kwiatkowska
  Antioxidants.2024; 13(12): 1559.     CrossRef
• AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis
  Jesús García-Bañuelos, Edén Oceguera-Contreras, Ana Sandoval-Rodríguez, Blanca Estela Bastidas-Ramírez, Silvia Lucano-Landeros, Daniela Gordillo-Bastidas, Belinda C. Gómez-Meda, Arturo Santos, Eira Cerda-Reyes, Juan Armendariz-Borunda
  Cells.2023; 12(17): 2127.     CrossRef
• Nutritional deficiency in patients with liver cirrhosis
  Maria S. Zhigalova, Vladimir V. Kiselev, Alla A. Ryk, Petr A. Yartsev
  Clinical nutrition and metabolism.2023; 4(4): 265.     CrossRef